7210 Wareham Drive, Tampa, FL 33647
January 20, 2024 Novo Nordisk and Eli Lilly aren’t the only drug companies active in the prescription diet drugs space. Viking Therapeutics has a dual GLP-1/GIP agonist in Phase 2 clinical trials for treating obesity and liver fat reduction for injectable and oral administration. Rhythm Pharmaceuticals has an FDA-approved treatment for the treatment of MC4R-pathway-related […]
More Obesity Drugs In The Pipeline Read More »
June 5, 2023 There is no doubt that the new obesity drugs (Wegovy, Ozempic) are hot and in high demand, but there is a disturbing new trend developing. Since the brand name drugs often cost $1,000 to $1,300 per month and are not covered by insurance, people are looking for cheaper alternatives. That’s where compounding
Semaglutide Gold Rush Is On, Compounding Pharmacies Read More »
May 1, 2023 According to management: “We’re pleased to see revenue and operating income both ahead of expectations in the quarter, as we continue to adjust to the changing dynamics of the business environment,” said Dan Chard, Medifast’s Chairman & Chief Executive Officer. “Sustainable long-term growth is at the core of our focus, and we are
Medifast Reports 1st Quarter Results Read More »
May 8, 2023 It’s official, Jenny Craig has closed its doors, and will not be transitioning to an e-commerce model, as it had indicated last week. Operations in Australia, however, will remain open. Last week, Jenny Craig had alerted employees to potential mass layoffs as it begins “winding down physical operations” and hunts for a
Jenny Craig Out of Business Read More »
April 25, 2023 In case you haven’t noticed, literally hundreds of new market research firms have emerged from India in the last 5-10 years, usually headquartered in Pune. Their websites look legit and professional, and they claim to be located in the United States. But, they are usually a one-person operation. Many of these companies
Beware Fake Weight Loss Research From India Read More »
April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With
Noom Is Testing Weight Loss Drugs Read More »
March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The
Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »
Feb. 23, 2023 As the new diet season progresses, we are left wondering about something. Conspicuously absent from Weight Watchers TV commercials is Oprah Winfrey, who at one time owned 10% of the company. What’s happening here? No TV ads featuring Oprah for the new 2023 diet season. Does she still own stock? How much?
Feb. 22, 2023 Medifast, the #1 weight loss company by revenues, topped earnings and revenue estimates. Fourth Quarter 2022 Full Year 2022 Highlights According to management: “We’ve placed a substantial focus on driving stability in customer retention rates, and with customer satisfaction metrics at all-time highs, we’ve seen retention return to and hold at normal
Medifast Reports 4th Qtr. & 2022 Results Read More »
Jan. 9, 2023 HMR (Health Management Resources), the weight loss program offered for the past 40 years in hospitals, clinics, and MD offices, was recently sold to Sanford Health, which runs the Profile by Sanford weight loss program. HMR has offered both medical and non-medical programs to consumers. In 2023, HMR programs and services will
HMR Acquired by Sanford Health, To Re-launch Read More »